Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 1,334,027 | 1,360,824 | 1,309,055 | 1,168,660 | 993,196 |
| Cost of Goods | 546,441 | 611,866 | 617,507 | 553,563 | 487,694 |
| Gross Profit | 787,586 | 748,958 | 691,548 | 615,097 | 505,502 |
| Operating Expenses | 631,293 | 528,007 | 527,172 | 459,627 | 425,446 |
| Operating Income | 156,734 | 221,817 | 164,883 | 156,033 | 80,750 |
| Interest Expense | 28,704 | 9,746 | 13,018 | 14,630 | 17,121 |
| Pre-tax Income | 128,030 | 212,071 | 151,865 | 141,403 | 63,629 |
| Income Tax | 30,722 | 44,392 | 34,307 | 26,002 | 20,254 |
| Net Income Continuous | 97,308 | 167,679 | 117,558 | 115,401 | 43,375 |
| Net Income | $97,308 | $167,679 | $117,558 | $115,401 | $43,375 |
| EPS Basic Total Ops | 2.06 | 3.33 | 2.32 | 2.27 | 0.85 |
| EPS Basic Continuous Ops | 2.06 | 3.33 | 2.32 | 2.27 | 0.85 |
| EPS Diluted Total Ops | 2.05 | 3.31 | 2.29 | 2.24 | 0.84 |
| EPS Diluted Continuous Ops | 2.05 | 3.31 | 2.29 | 2.24 | 0.84 |
| EPS Diluted Before Non-Recurring Items | 4.96 | 4.57 | 3.96 | 3.03 | 2.58 |
| EBITDA(a) | $274,265 | $352,359 | $265,445 | $249,340 | $181,901 |